XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2022
Net Loss Per Share  
Net Loss Per Share

9. Net Loss Per Share

Basic and diluted net loss per share for the three and six months ended June 30, 2022 and 2021 was calculated as follows (in thousands except share and per share amounts).

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Numerator:

 

  

  

  

  

Net loss

$

(17,024)

$

(9,526)

$

(27,400)

$

(18,660)

Net loss attributable to common stockholders for basic and diluted loss per share

$

(17,024)

$

(9,526)

$

(27,400)

$

(18,660)

Denominator:

 

 

 

 

Weighted average number of common shares outstanding – basic and diluted

 

113,248,937

 

76,389,525

 

113,248,937

 

76,384,077

Net loss per share attributable to common stockholders – basic and diluted

$

(0.15)

$

(0.12)

$

(0.24)

$

(0.24)

Included within weighted average common shares outstanding for the three and six months ended June 30, 2022 and for the three and six months ended June 30, 2021 are 24,930,483 and 16,718,418, respectively, common shares issuable upon the exercise of the pre-funded warrants and penny warrants, as the warrants are exercisable at any time for nominal consideration, and as such, the shares are considered outstanding for the purpose of calculating basic and diluted net loss per share attributable to common stockholders.

The Company’s potentially dilutive securities include RSUs, stock options and warrants. These securities were excluded from the computations of diluted net loss per share for the three and six months ended June 30, 2022 and 2021, as the effect would be to reduce the net loss per share. The following table includes the potential shares of common stock, presented based on amounts outstanding at each period end, that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Restricted stock units to purchase common stock

3,510,606

935,606

3,510,606

935,606

Options to purchase common stock

 

9,046,420

 

8,386,135

9,046,420

 

8,386,135

Warrants to purchase common stock

35,455,674

35,974,337

35,455,674

35,974,337

 

48,012,700

 

45,296,078

48,012,700

 

45,296,078